The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells.

Abstract

TFPI-2 (tissue factor pathway inhibitor-2) has recently been recognized as a new tumour suppressor gene. Low expression of this protein in several types of cancers allows for enhanced tumour growth, invasion and metastasis. To investigate the molecular mechanism responsible for the tumour-suppressor effects of TFPI-2, we performed yeast two-hybrid analysis and identified PSAP (prosaposin) as a TFPI-2-interacting partner. This interaction was confirmed by co-immunoprecipitation and immunofluorescence. The region of TFPI-2 that interacts with PSAP is located in the KD2 (Kunitz-type domain 2). Further study showed that PSAP does not affect the function of TFPI-2 as a serine proteinase inhibitor, but that TFPI-2 could inhibit the invasion-promoting effects of PSAP in human HT1080 fibrosarcoma cells. The results of the present study revealed that TFPI-2 interacts with PSAP, which may play an important role in the physiology and pathology of diseases such as cancer.

• Authors: Chundi Xu, Fenge Deng, Zuohua Mao, Jing Zhang, Huijun Wang, Jiping Wang, Jingui Mu, Shanshan Deng, Duan Ma
• Journal: The Biochemical journal (Biochem J) Vol. 441 Issue 2 Pg. 665-74 (Jan 15 2012) ISSN: 1470-8728 [Electronic] England
• PMID: 21943334 (Publication Type: Journal Article)

Chemical References

• Glycoproteins
• PSAP protein, human
• Saposins
• Serine Proteinase Inhibitors
• tissue-factor-pathway inhibitor 2
• Matrix Metalloproteinases

Topics

• Animals
• Binding Sites
• COS Cells
• Cell Movement (drug effects, ethics)
• Chlorocebus aethiops
• Fibrosarcoma (physiopathology)
• Glycoproteins (metabolism)
• HEK293 Cells
• Humans
• Matrix Metalloproteinases (metabolism)
• Neoplasm Invasiveness
• Protein Structure, Tertiary
• Saposins (metabolism, pharmacology)
• Serine Proteinase Inhibitors (genetics)
• Two-Hybrid System Techniques